AI Article Synopsis

  • The study assessed reimbursement for genetic counseling services at one institution over a four-year period, focusing on patient encounters with the 96040 CPT® code.
  • A total of 582 eligible encounters were reviewed, revealing statistics on reimbursement rates, payor types, and ICD-9 code reimbursement.
  • Significant differences in reimbursement were found between payors that credential genetic counselors and those that do not, while no notable differences were observed in reimbursement rates for different primary diagnostic codes.

Article Abstract

Reimbursement for genetic counseling services was examined at a single institution. Patient encounters utilizing the 96040 CPT® code from 7/31/2009 through 7/31/2013 were reviewed. Exclusion criteria included billing records of patients seen by a physician the same day, self-pay, Medicaid, and Medicare patients. Of the 8,630 encounters with a genetic counselor, 582 encounters were eligible for review. Descriptive statistics (i.e., percentage of encounters receiving some level of reimbursement, average reimbursement rate, number of third party payors providing any level of reimbursement, and number of ICD-9 codes receiving any level of reimbursement) depicted reimbursement of the 96040 CPT® code for the encounters analyzed. Statistical analysis found a significant difference in reimbursement between third party payors that do and do not credential genetic counselors (p < .0001). There was no statistically significant difference between reimbursement rates for primary diagnostic ICD-9 codes when compared to primary diagnostic ICD-9 V codes used. Results will provide a useful baseline for local and national comparisons due to the paucity of data regarding CPT® 96040.

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10897-016-0062-7DOI Listing

Publication Analysis

Top Keywords

level reimbursement
12
reimbursement genetic
8
genetic counseling
8
counseling services
8
single institution
8
96040 cpt®
8
cpt® code
8
receiving level
8
third party
8
party payors
8

Similar Publications

Family child care (FCC) offers a promising setting for obesity prevention, yet interventions have had varied success, potentially due to insufficient stakeholder input. This study aimed to explore barriers, facilitators, and preferences for healthy eating and physical activity interventions among Australian FCC educators and organization staff. Semi-structured interviews were conducted with 15 FCC educators and 6 staff members, using the framework method for data analysis.

View Article and Find Full Text PDF

Clinical guidelines typically endorse conventional therapies such as 5-aminosalicylic acid (5-ASA) as the mainstay of ulcerative colitis management. However, the degree of adoption and application of guideline recommendations by physicians within Asia remains unclear. This study aims to understand the prescribing patterns of 5-ASA and implementation of current guideline recommendations across Asian clinical practice.

View Article and Find Full Text PDF

Modelling vitamin D fortification scenarios for the Australian population.

J Nutr

January 2025

Institute for Physical Activity and Nutrition (IPAN), School of Exercise and Nutrition Sciences, Deakin University, Geelong VIC 3125, Australia. Electronic address:

Background: Low vitamin D status (circulating 25-hydroxyvitamin D concentration <50 nmol/L) is prevalent in Australia, and 95% of Australians have been estimated to have low vitamin D intake (mean range 1.8-3.2 μg/day).

View Article and Find Full Text PDF

Upregulation of Cyclin E1 and subsequent activation of CDK2 accelerates cell cycle progression from G1 to S phase and is a common oncogenic driver in gynecological malignancies. WEE1 kinase counteracts the effects of Cyclin E1/CDK2 activation by regulating multiple cell cycle checkpoints. Here we characterized the relationship between Cyclin E1/CDK2 activation and sensitivity to the selective WEE1 inhibitor azenosertib.

View Article and Find Full Text PDF

The COVID-19 pandemic challenged healthcare delivery, especially cancer care. Telemedicine emerged as an important tool to reduce disease transmission risks, maintain continuity of care, and improve accessibility. This study explores temporary measures during the pandemic as well as challenges and facilitators for integrating telemedicine into the European healthcare landscape in five case countries, focusing on cancer care.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!